Award

Molecular Pathogenesis of Monoclonal B Cell Lymphocytosis and CLL

Description: Chronic lymphocytic leukemia (CLL) is the most prevalent leukemia in the United States, with approximately 90,000 affected individuals and 4,500 attributable deaths per year. Monoclonal B lymphocytosis is an identified precursor state for CLL, and is approximately 100 times more prevalent than CLL. The experiments described herein will clarify the biology of pre-emergent CLL, discover the determinants of progression from MBL to CLL, and identify novel targets for therapeutic intervention in CLL.
Funding type: career_development
Funder scheme: K08
Start date: 2011-08-01
End date: 2016-07-31
Investigator: MARK C LANASA
Institution: DUKE UNIVERSITY
Subfield: Genetics
Field: Medicine
Funded outputs count: 18
Funder award ID: K08CA134919
OpenAlex ID: G6134872255
2021 · Amy Moore, Mitchell J. Machiela, et al. · Journal of Translational Genetics and Genomics
2020 · Susan L. Slager, Mark C. Lanasa, et al. · Blood · 37
2020 · Amy Moore, Eleanor Kane, et al. · Frontiers in Oncology · 8
2019 · Lennox Din, Mohammad Sheikh, et al. · Genetic Epidemiology · 38
2017 · Sasha Bernatsky, Héctor A Velásquez García, et al. · Lupus Science & Medicine · 28
2017 · Philip J. Law, Sonja I. Berndt, et al. · Nature Communications · 97
2016 · Sonja I. Berndt, Nicola J. Camp, et al. · Nature Communications · 112
2016 · Mitchell J. Machiela, Qing Lan, et al. · Human Molecular Genetics · 58
2013 · Daphne R. Friedman, Mark C. Lanasa, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 33
2013 · Sonja I Berndt, Christine F Skibola, et al. · Nature Genetics · 205
2013 · Scott J. Hebbring, Susan L. Slager, et al. · Blood · 11
2012 · Susan L. Slager, Christine F. Skibola, et al. · Blood · 74
2012 · Catherine C. Coombs, Lorenzo Falchi, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 24
Year
Topic